Long acting β-2-agonists and their use as medicaments

US7160882B2 · kind B2 · utility

Assignee

• Boehringer Ingelheim International GmbH · DE

Inventors

• Thierry Bouyssou · Mietingen, DE
• Ingo Konetzki · Warthausen, DE
• Philipp Lustenberger · Warthausen, DE
• Juergen Mack · Biberach an der Riß, DE
• Andreas Schnapp · Biberach, DE
• Dieter Wiedenmayer · Biberach an der Riß, DE
• Christoph Hoenke · Ingelheim am Rhein, DE
• Klaus Rudolf · Warthausen, DE

Key dates

• Filing date: Jan 5, 2005
• Grant date: Jan 9, 2007
• Expiry date: Jan 5, 2025

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07D413/12
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The present invention relates to compounds of formula 1wherein the groups X, Ra, Rb, R1, R1′, R2, R2′, R2″, R2′″, V and n may have the meanings given in the claims and in the specification, and the use thereof as pharmaceutical compositions, particularly for the treatment of inflammatory and obstructive respiratory complaints.